From the publishers of JADPRO

Gastrointestinal Stromal Tumor Resource Center

Advertisement

Two decades of gastrointestinal stromal tumor management with first-line treatment: A case report

Last Updated: Thursday, January 23, 2025

In this case study, a man in his forties with a jejunal GIST was treated with imatinib. After initial surgery and recurrence, he received imatinib therapy, stopped, and restarted due to further recurrence. He has been on imatinib with good tolerance until March 2024, highlighting the drug's long-term potential.

 

Cureus
Advertisement
News & Literature Highlights
Advertisement
Advertisement